Does neoadjuvant hormone therapy for early prostate cancer affect cognition?
This pilot study suggests that short-term LHRH therapy for early-stage prostate cancer has modest short-term consequences on men's cognitive functioning; a larger prospective study is warranted.
The MAF may be a potential predictive factor of TKI treatment efficacy in patients with AELAd carrying the L858Rm.